Search by Drug Name or NDC
NDC 68180-0560-03 QUININE SULFATE 324 mg/1 Details
QUININE SULFATE 324 mg/1
QUININE SULFATE is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is QUININE SULFATE.
MedlinePlus Drug Summary
Quinine is used alone or with other medications to treat malaria (a serious or life-threatening illness that is spread by mosquitos in certain parts of the world). Quinine should not be used to prevent malaria. Quinine is in a class of medications called antimalarials. It works by killing the organisms that cause malaria.
Related Packages: 68180-0560-03Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Quinine
Product Information
| NDC | 68180-0560 |
|---|---|
| Product ID | 68180-560_93b0a585-9424-4e78-93c0-2e0c151475f1 |
| Associated GPIs | 13000060100119 |
| GCN Sequence Number | 048201 |
| GCN Sequence Number Description | quinine sulfate CAPSULE 324 MG ORAL |
| HIC3 | W4A |
| HIC3 Description | ANTIMALARIAL DRUGS |
| GCN | 25092 |
| HICL Sequence Number | 004142 |
| HICL Sequence Number Description | QUININE SULFATE |
| Brand/Generic | Generic |
| Proprietary Name | QUININE SULFATE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | QUININE SULFATE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 324 |
| Active Ingredient Units | mg/1 |
| Substance Name | QUININE SULFATE |
| Labeler Name | Lupin Pharmaceuticals, Inc. |
| Pharmaceutical Class | Antimalarial [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA203112 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68180-0560-03 (68180056003)
| NDC Package Code | 68180-560-03 |
|---|---|
| Billing NDC | 68180056003 |
| Package | 1000 CAPSULE in 1 BOTTLE (68180-560-03) |
| Marketing Start Date | 2015-08-04 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |